The Biopharma SHAKTI scheme has the potential to fundamentally reshape how biologics are developed in India. It will aid in accelerating the transition from traditional animal-based testing to advanced human-relevant, non-animal models (NAMs). Read here to learn more. The Union Budget 2026-27 marked a major shift in India’s pharmaceutical strategy with the launch of the […]
The post BioPharma SHAKTI Scheme appeared first on ClearIAS.